Semaglutide 2.4mg

Semaglutide 2.4mg is a medication that belongs to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It is primarily used for the treatment of type 2 diabetes mellitus in adults.

Semaglutide 2.4mg is a once-weekly injectable formulation that helps to improve blood sugar control by stimulating the release of insulin and reducing the production of glucagon, a hormone that increases blood sugar levels.

Clinical studies have shown that it can effectively lower HbA1c levels, which is a long-term indicator of blood sugar control. Additionally, it has been found to promote weight loss in individuals with type 2 diabetes.

It works by slowing down the emptying of the stomach, increasing feelings of fullness, and reducing appetite. This can be particularly beneficial for those who struggle with weight management alongside their diabetes management.

Showing the single result